The hyperactivation of the PI3K/AKT pathway has also been linked with the induction of EMT in human mammary cancer cells and the upregulation of PD-L1, in addition to the expression of a well-known stem cell marker: the cluster of differentiation 44 (CD44) molecule [112]. This evidence concerns the gene AKT1 and breast cancer.